Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01831752 · ClinicalTrials.gov registry record
Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2
A clinical trial, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- 9
- Enrollment target
NCT01831752: Completed study, sponsored by Sansum Diabetes Research Institute.
NCT01831752 is a clinical trial that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01831752 has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
This study is for adults and adolescents with type 1 diabetes. The purpose of this study is to learn more about an investigational system to measure blood glucose. This system does not require blood to be drawn from the body, and it does not require a glucose sensor to be worn under the skin (subcutaneously). This device instead estimates blood glucose levels by shining infrared light on the skin and then using sophisticated statistical analysis on how the light bounces back or gets absorbed (spectral data). The researchers in this study will compare the accuracy of the new device to glucose measurement devices that are already approved by the FDA, including glucose meters and subcutaneous continuous glucose monitoring (CGM) sensors. Information learned from this study will be used in the development of tools for managing diabetes.
Primary Outcome
To generate a non-invasive blood glucose measurement with continuous glucose monitor data and alternate site data.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-06 |
What the finished NCT01831752 record still lists
NCT01831752 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01831752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01831752 about?
NCT01831752 is a clinical study titled "Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2". This study is for adults and adolescents with type 1 diabetes. The purpose of this study is to learn more about an investigational system to measure blood glucose. This system does not require blood to be drawn from the body, and it does not require a glucose sensor to be worn under the skin (subcut...
What is the current status of trial NCT01831752?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2013-02. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01831752?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia